Related Articles
Effect of integrin receptor‑targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy Retraction in /10.3892/ol.2021.12611
Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma
Gene therapy for ovarian cancer (review)
A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells
hCAR-EGFP fusion receptor in human follicular lymphoma B cells - A model for adenoviral gene therapy for B cell malignancies